ACCESS CHINA has been held every quarter since 2020 and serves as a China cross-border corporate access platform. In its 2 years of bringing together international and China Biotech BDs and CEOs, ACCESS CHINA creates invaluable BD opportunities by directly connecting and meeting with the right partners for development, licensing or commercial collaborations.
Our “ACCESS CHINA Biotech Forum Spring Showcase 2022” was held online from April 18th to 19th, 2022. ACCESS CHINA forum had over 1000 participants from China pharma and Biotech companies. This event was divided into the following sessions:
- US and Australia biotech Company Roadshows (Companies looking for out-licensing in China)
- European and Asia biotech Company Roadshows (Companies looking for out-licensing in China)
- China biotech Company Roadshows (Companies looking for out-licensing in ex-China or global)
- China fundraising Company Roadshows (in Chinese; Companies looking for fundraising in China)
BioToChina.org 